{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:26:27Z","timestamp":1793312787375,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-025-00508-5","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:37:22Z","timestamp":1766882242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Prevalence and Risk Factors of Hepatitis B, Hepatitis C, and Hepatitis D Coinfection in Iran\u2019s General Population Over the Past 25 Years: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Malihe","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosar","family":"Kordkatuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Naswa","family":"Makokha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-4190","authenticated-orcid":false,"given":"Abdolvahab","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-8519","authenticated-orcid":false,"given":"Fatemeh","family":"Mehravar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hijikata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"issue":"3","key":"508_CR1","doi-asserted-by":"publisher","first-page":"e0151946","DOI":"10.1371\/journal.pone.0151946","volume":"11","author":"F Bagheri Amiri","year":"2016","unstructured":"Bagheri Amiri F, Mostafavi E, Mirzazadeh A. HIV, HBV, and HCV coinfection prevalence in Iran\u2013A systematic review and Meta-Analysis. PLoS ONE. 2016;11(3):e0151946.","journal-title":"PLoS ONE"},{"issue":"2","key":"508_CR2","doi-asserted-by":"publisher","first-page":"e64808","DOI":"10.5812\/modernc.64808","volume":"14","author":"S Ahmadi-Ghezeldasht","year":"2017","unstructured":"Ahmadi-Ghezeldasht S, Hedayati-Moghaddam MR, Akbarin MM. The prevalence of hepatitis B and C virus Co-Infection among a group of the Iranian population. Mod Care J. 2017;14(2):e64808.","journal-title":"Mod Care J"},{"key":"508_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12985-018-1060-1","volume":"15","author":"MM Badawi","year":"2018","unstructured":"Badawi MM, Atif MS, Mustafa YY. Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan. Virol J. 2018;15:148.","journal-title":"Virol J"},{"issue":"7","key":"508_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071115","volume":"16","author":"T Stroffolini","year":"2024","unstructured":"Stroffolini T, Stroffolini G. Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review. Viruses. 2024;16(7):1115.","journal-title":"Viruses"},{"issue":"4","key":"508_CR5","doi-asserted-by":"publisher","first-page":"135965352311896","DOI":"10.1177\/13596535231189643","volume":"28","author":"Q Maqsood","year":"2023","unstructured":"Maqsood Q, Sumrin A, Iqbal M, Younas S, Hussain N, Mahnoor M, Wajid A. Hepatitis C virus\/Hepatitis B virus coinfection: current prospectives. Antivir Ther. 2023;28(4):13596535231189643.","journal-title":"Antivir Ther"},{"key":"508_CR6","unstructured":"UNAIDS. Report on the global AIDS epidemic. UNAIDS. 2012. Available at: http:\/\/files.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_with_ annexes_en.pdf . Accessed Nov 2017."},{"key":"508_CR7","unstructured":"Global progress report on HIV, viral hepatitis and sexually transmitted infections. 2021. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/ (Accessed July 2021)."},{"key":"508_CR8","unstructured":"World Health Organization. Hepatitis B. Fact sheet No. 204. WHO. 2013. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ (Accessed Nov 2017)."},{"issue":"4","key":"508_CR9","first-page":"1101","volume":"22","author":"Y-F Liaw","year":"1995","unstructured":"Liaw Y-F. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatol. 1995;22(4):1101\u20138.","journal-title":"Hepatol"},{"key":"508_CR10","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2019-0066","author":"F Dehghani-Dehej","year":"2020","unstructured":"Dehghani-Dehej F, Hosseini Z, Mortazkar P, Khanaliha K, Esghaei M, Fakhim A, Bokharaei-Salim F. Prevalence of HCV, and\/or HBV coinfection in Iranian HIV-infected patients. Future Virol. 2020. https:\/\/doi.org\/10.2217\/fvl-2019-0066.","journal-title":"Future Virol"},{"issue":"Suppl 13","key":"508_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02990102","volume":"37","author":"YF Liaw","year":"2002","unstructured":"Liaw YF. Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. J Gastroenterol. 2002;37(Suppl 13):65\u20138.","journal-title":"J Gastroenterol"},{"issue":"1","key":"508_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.30699\/ijmm.18.1.1","volume":"18","author":"N Ghorbani","year":"2024","unstructured":"Ghorbani N, Alamdary A, Khanizadeh S, Birjandi M, Ajorloo M. Epidemiological study of hepatitis D virus in HBsAg positive patients in Khorramabad City, West of Iran, 2019. Iran J Med Microbiol. 2024;18(1):1\u20137.","journal-title":"Iran J Med Microbiol"},{"issue":"1","key":"508_CR13","doi-asserted-by":"publisher","first-page":"e8210","DOI":"10.5812\/hepatmon.8210","volume":"13","author":"N Amini","year":"2013","unstructured":"Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Hosseini SYS, Rizzetto M. Prevalence of hepatitis d in the Eastern mediterranean region: systematic review and meta-analysis. Hepat Mon. 2013;13(1):e8210.","journal-title":"Hepat Mon"},{"issue":"5","key":"508_CR14","doi-asserted-by":"publisher","first-page":"e42866","DOI":"10.5812\/hepatmon.42866","volume":"17","author":"G Sharifzadeh","year":"2017","unstructured":"Sharifzadeh G, Namaei MH, Ebrahimzadeh A, Azarkar Z, Fereidouni M, Bijari B, et al. Prevalence of hepatitis D virus infection and associated factors among HBsAg-positive patients in Birjand, Iran, 2012\u20132014. Hepat Mon. 2017;17(5):e42866.","journal-title":"Hepat Mon"},{"issue":"2","key":"508_CR15","first-page":"145","volume":"11","author":"B Sayad","year":"2018","unstructured":"Sayad B, Naderi Y, Alavian SM, Najafi F, Janbakhsh A, Mansouri F, et al. Hepatitis D virus infection in Kermanshah, West of iran: Seroprevalence and viremic infections. Gastroenterol Hepatol Bed Bench. 2018;11(2):145\u201352.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"3","key":"508_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5812\/hepatmon.5121","volume":"12","author":"MR Ghadir","year":"2012","unstructured":"Ghadir MR, Belbasi M, Heidari A, Sarkeshikian SS, Kabiri A, Ghanooni AH, et al. Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in Qom province, center of Iran. Hepat Mon. 2012;12(3):205\u20138.","journal-title":"Hepat Mon"},{"issue":"1","key":"508_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12879-019-4661-4","volume":"19","author":"MA Behzadi","year":"2019","unstructured":"Behzadi MA, Leyva-Grado VH, Namayandeh M, Ziyaeyan A, Feyznezhad R, Dorzaban H, et al. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the hormozgan Province Southern Iran. BMC Infect Dis. 2019;19(1):1027.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"508_CR18","doi-asserted-by":"publisher","first-page":"e93956","DOI":"10.5812\/modernc.93956","volume":"16","author":"S Ahmadi Ghezeldasht","year":"2019","unstructured":"Ahmadi Ghezeldasht S, Hedayati-Moghaddam MR, Mosavat A, Akbarin MM. Sero-Prevalence of hepatitis D virus infection among hepatitis B surface antigen positive patients in Mashhad, Northeastern Iran. Mod Care J. 2019;16(3):e93956.","journal-title":"Mod Care J"},{"issue":"3","key":"508_CR19","first-page":"144","volume":"7","author":"SME Tahaei","year":"2014","unstructured":"Tahaei SME, Mohebbi SR, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P, et al. Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2014;7(3):144\u201350.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"508_CR20","first-page":"260","volume":"51","author":"A Bakhshipour","year":"2013","unstructured":"Bakhshipour A, Mashhadi M, Mohammadi M, Nezam SK. Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Med Iran. 2013;51(4):260\u20134.","journal-title":"Acta Med Iran"},{"issue":"12","key":"508_CR21","first-page":"1906","volume":"47","author":"P Sharifan","year":"2018","unstructured":"Sharifan P, Amoueian S. Histological and serological epidemiology of hepatitis delta virus coinfection among patients with chronic active hepatitis B virus in Razavi Khorasan Province, Northeastern Iran. Iran J Public Health. 2018;47(12):1906\u201312.","journal-title":"Iran J Public Health"},{"issue":"10","key":"508_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","volume":"221","author":"Z Miao","year":"2020","unstructured":"Miao Z, Zhang S, Ou X, Li S, Ma Z, Wang W, Peppelenbosch MP, Liu J, Pan Q. Estimating the global Prevalence, disease Progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020;221(10):1677\u201387.","journal-title":"J Infect Dis"},{"issue":"3","key":"508_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut. 2000;46(3):420\u20136.","journal-title":"Gut"},{"issue":"8","key":"508_CR24","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1007\/s10620-023-07960-y","volume":"68","author":"C Pan","year":"2023","unstructured":"Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023;68(8):3237\u201348.","journal-title":"Dig Dis Sci"},{"key":"508_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"508_CR26","unstructured":"PROSPERO: A registry for systematic review protocols | Augustus C. Long Health Sciences Library. (2022). Available online at: https:\/\/library.cumc.columbia.edu\/insight\/prospero-registry-systematic-review-protocols (Accessed June 10, 2022)."},{"key":"508_CR27","unstructured":"https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"6","key":"508_CR28","doi-asserted-by":"publisher","first-page":"e67968","DOI":"10.5812\/archcid.3075","volume":"13","author":"B Eshraghi Mosa Abadi","year":"2018","unstructured":"Eshraghi Mosa Abadi B, Kandelouei T, Eslami G, Asli M, Vaezjalali M. Prevalence and risk factors for occult hepatitis B and HIV infections among HCV infected intravenous drug Users, Tehran, Iran. Arch Clin Infect Dis. 2018;13(6):e67968.","journal-title":"Arch Clin Infect Dis"},{"key":"508_CR29","doi-asserted-by":"crossref","unstructured":"Afkhamzadeh A, Zandvakili F, Rahmani K, Bahmani A. High hepatitis C prevalence in medium-term residential addiction treatment centers in Kurdistan province, Iran, 2018. Int J High Risk Behav Addict. 2019; 8(4).","DOI":"10.5812\/ijhrba.90078"},{"key":"508_CR30","first-page":"64","volume":"17","author":"SA Ghezeldasht","year":"2017","unstructured":"Ghezeldasht SA, Hedayati-Moghaddam MR, Akbarin MM. Prevalence of hepatitis D virus infection in individuals with hepatitis B surface antigenemia in Mash-Had, Northeast of Iran. Hepat Mon. 2017;17:64.","journal-title":"Hepat Mon"},{"issue":"2","key":"508_CR31","first-page":"472","volume":"35","author":"Z Allamehzadeh","year":"2018","unstructured":"Allamehzadeh Z, Hamadiyan H, Raeini MI, Shams SA, Koolivand M. Prevalence of hepatitis B and C in thalassemia major patients in South of Iran-Bandar Abbas. Trop Biomed. 2018;35(2):472\u20137.","journal-title":"Trop Biomed"},{"issue":"4","key":"508_CR32","first-page":"269","volume":"11","author":"B Ataei","year":"2011","unstructured":"Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, et al. Hepatitis D virus infection in Isfahan, central iran: prevalence and risk factors among chronic HBV infection cases. Hepat Mon. 2011;11(4):269\u201372.","journal-title":"Hepat Mon"},{"issue":"3","key":"508_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/apm.12137","volume":"122","author":"MS Attaran","year":"2014","unstructured":"Attaran MS, Sharifi Z, Hosseini SM, Samei S, Ataee Z. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran. Apmis. 2014;122(3):243\u20137.","journal-title":"Apmis"},{"key":"508_CR34","doi-asserted-by":"crossref","unstructured":"Azad AR, Zargar M, Zolfaghari MR, Mohammadbeigi A. The prevalence of hepatitis B and D viruses and evaluating YMDD mutation in HBV-Suspected patients in Qom Province, Iran. JJM.2020; 13(2).","DOI":"10.5812\/jjm.100038"},{"issue":"4","key":"508_CR35","first-page":"760","volume":"11","author":"H Azarbakhsh","year":"2023","unstructured":"Azarbakhsh H, Ghelichi-Ghojogh M, Piraee E, Shojaie L, Nikbakht HA, Hemmati A, et al. The epidemiology and trend of incidence of hepatitis B and C infections in Southern Iran (2014\u20132020). JHSSS. 2023;11(4):760\u20138.","journal-title":"JHSSS"},{"issue":"2","key":"508_CR36","first-page":"193","volume":"32","author":"A Doosti","year":"2009","unstructured":"Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E, Adeli A, Mahboudi F. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in West Iran. New Microbiol. 2009;32(2):193\u20138.","journal-title":"New Microbiol"},{"key":"508_CR37","doi-asserted-by":"crossref","unstructured":"Faghihi SH, Azarbakhsh H, Piraee E. Epidemiological study of hepatitis B and hepatitis C infection in Kohgiluyeh and Boyer-Ahmad Province (Iran) from 2008 to 2021: a cross-sectional study. Health Sci Rep. 2024; 7(2).","DOI":"10.1002\/hsr2.1812"},{"key":"508_CR38","doi-asserted-by":"crossref","unstructured":"Ghamari S, Alavian SM, Rizzetto M, Olivero A, Smedile A, Khedive A et al. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical Pictures. Hepat Mon 2013; 13(8).","DOI":"10.5812\/hepatmon.6731"},{"issue":"5","key":"508_CR39","first-page":"619","volume":"7","author":"MS Ghannad","year":"2013","unstructured":"Ghannad MS, Hojati SA, Mirzaei M, Sahebkar A. Prevalence of hepatitis B and hepatitis C in patients referred to health centers in the Hamadan province, iran: an epidemiologic study of infections between 2004 and 2007. Asian Biomed. 2013;7(5):619\u201325.","journal-title":"Asian Biomed"},{"issue":"10","key":"508_CR40","first-page":"1751","volume":"10","author":"G Roshandel","year":"2007","unstructured":"Roshandel G, Semnani S, Abdolahi N, Keshtkar AA, Besharat S, Joshaghani H, et al. Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. PJBS. 2007;10(10):1751\u20134.","journal-title":"PJBS"},{"issue":"4","key":"508_CR41","first-page":"287","volume":"9","author":"E Hajiani","year":"2009","unstructured":"Hajiani E, Hashemi SJ, Jalali F. Seroprevalence of delta hepatitis in patients with chronic hepatitis B and its clinical impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4):287\u201392.","journal-title":"Hepat Mon"},{"issue":"3","key":"508_CR42","first-page":"225","volume":"14","author":"H Hatami","year":"2018","unstructured":"Hatami H, Namdaritabar H, Lotfaliany M, Akbarpour S, Zafari N. Occurrence of HBV and HCV and their probable risk factors in the newly registered HIV\/AIDS patients in the center for control of communicable diseases in 2016. IJE. 2018;14(3):225\u201333.","journal-title":"IJE"},{"issue":"12","key":"508_CR43","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/jmv.25808","volume":"92","author":"S Jamshidi","year":"2020","unstructured":"Jamshidi S, Bokharaei-Salim F, Esghaei M, Bastani MN, Garshasbi S, Chavoshpour S, et al. Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus-infected individuals. J Med Virol. 2020;92(12):3354\u201364.","journal-title":"J Med Virol."},{"issue":"18","key":"508_CR44","first-page":"3976","volume":"6","author":"L Kasraian","year":"2012","unstructured":"Kasraian L, Tavassoli A, Shayegan M, Alavian SM. The prevalence and risk factor of hepatitis B and D in Shiraz blood donors. Afr J Microbiol Res. 2012;6(18):3976\u20139.","journal-title":"Afr J Microbiol Res"},{"issue":"6","key":"508_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/tme.12163","volume":"24","author":"M Keshvari","year":"2014","unstructured":"Keshvari M, Alavian SM, Aghaee B, Behnava B, Mahdavi M, Fesharaki MG, et al. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from hepatitis clinic of Iranian blood transfusion organization. Transfus Med. 2014;24(6):411\u20137.","journal-title":"Transfus Med"},{"issue":"1","key":"508_CR46","first-page":"16","volume":"9","author":"S Khazaei","year":"2018","unstructured":"Khazaei S, Karami M, Ayubi E, Mohammadbeigi A, Hasanbeigi A, Mansori K, et al. Trends in epidemiology of hepatitis B and C infections in Ilam province: National notifiable diseases surveillance system data. CJIM. 2018;9(1):16\u201321.","journal-title":"CJIM"},{"key":"508_CR47","doi-asserted-by":"crossref","unstructured":"Mohammadi M, Talei G, Sheikhian A, Ebrahimzade F, Pournia Y, Ghasemi E et al. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virol J. 2009; 6.","DOI":"10.1186\/1743-422X-6-202"},{"issue":"3","key":"508_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1258\/td.2011.100418","volume":"41","author":"A Moradi","year":"2011","unstructured":"Moradi A, Khodabakhshi B, Sadeghipour M, Besharat S, Tabarraei A. Concurrent infections of hepatitis C and HIV in hepatitis B patients in the north-east of Iran. Trop Doct. 2011;41(3):129\u201331.","journal-title":"Trop Doct"},{"issue":"1","key":"508_CR49","doi-asserted-by":"publisher","first-page":"e25028","DOI":"10.5812\/ijhrba.25028","volume":"5","author":"H Norouzian","year":"2016","unstructured":"Norouzian H, Gholami M, Shakib P, Goudarzi G, Ghobadian Diali H, Rezvani A. Prevalence of HCV infections and Co-Infection with HBV and HIV and associated risk factors among addicts in drug treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict. 2016;5(1):e25028.","journal-title":"Int J High Risk Behav Addict"},{"issue":"1","key":"508_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.15171\/hpp.2020.07","volume":"10","author":"AA Pouri","year":"2020","unstructured":"Pouri AA, Ghojazadeh M, Baiaz B, Hamzavi FS, Pourasghari B, Somi MH. Prevalence of hepatitis D virus among HBsAg-positive individuals, 2015\u20132016: Azar cohort study. Health Promot Perspect. 2020;10(1):38\u201342.","journal-title":"Health Promot Perspect"},{"issue":"3","key":"508_CR51","first-page":"227","volume":"41","author":"G Roshandel","year":"2008","unstructured":"Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, Northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227\u201330.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"508_CR52","first-page":"252","volume":"49","author":"S SeyedAlinaghi","year":"2011","unstructured":"SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, et al. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran. 2011;49(4):252\u20137.","journal-title":"Acta Med Iran"},{"issue":"10","key":"508_CR53","first-page":"1516","volume":"28","author":"B Sharifi-Mood","year":"2007","unstructured":"Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections an patient with hemophilia in Zahedan, Southeast Iran. Saudi Med J. 2007;28(10):1516\u20139.","journal-title":"Saudi Med J"},{"issue":"1","key":"508_CR54","first-page":"13","volume":"14","author":"A Shavakhi","year":"2009","unstructured":"Shavakhi A, Norinayer B, Esteghamat FS, Seghatoleslami M, Khodadustan M, Somi MH, et al. Occult hepatitis B among Iranian hepatitis C patients. J Res Med Sci. 2009;14(1):13\u20137.","journal-title":"J Res Med Sci"},{"issue":"3","key":"508_CR55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1258\/td.2009.080365","volume":"39","author":"MH Somi","year":"2009","unstructured":"Somi MH, Farhang S, Miri SM, Pouri AA, Mjidi G, Alavian SM. The frequency of hepatitis D virus in patients with hepatitis B in iran: an increasing rate? Trop Doct. 2009;39(3):154\u20136.","journal-title":"Trop Doct"},{"issue":"4","key":"508_CR56","first-page":"248","volume":"8","author":"SA Taghavi","year":"2008","unstructured":"Taghavi SA, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in chronic active hepatitis B: Prevalence, liver enzyme levels and Histopathology-an epidemiological study in Shiraz, Southern Iran, 2003\u20132004. Hepat Mon. 2008;8(4):248\u201351.","journal-title":"Hepat Mon"},{"issue":"2","key":"508_CR57","first-page":"130","volume":"11","author":"E Tajbakhsh","year":"2011","unstructured":"Tajbakhsh E, Abbasian B, Esmaeili A, Behjati M. Seroprevalence of anti-HDV Ab and socioepidemiological characteristics among HBsAg-positive blood donors in Charmahal-o-Bakhtiyari Province. Iran Hepat Mon. 2011;11(2):130\u20131.","journal-title":"Iran Hepat Mon"},{"issue":"1","key":"508_CR58","first-page":"25","volume":"5","author":"M Talebi-Taher","year":"2010","unstructured":"Talebi-Taher M, Mohit M, Avanessians TB. Viral hepatitis in patients hospitalized in two teaching hospitals, Tehran, Iran. Iran. J. Clin. Infect. Dis. 2010;5(1):25\u20139.","journal-title":"Dis"},{"key":"508_CR59","unstructured":"Tarahomi M, Eslami M, Rad RH, Pooya P, Habibian F, Neyestanaki MHK et al. Hepatitis B and hepatitis C infections in the City of Semnan between 2021 and 2022: a seroepidemiological research. Iran Red Crescent Med J 2024; 26(1)."},{"issue":"1","key":"508_CR60","first-page":"54","volume":"54","author":"A Yari","year":"2016","unstructured":"Yari A, Yousefzadeh H, Tahaghoghi S, Ghazvini K. Prevalence of hepatitis B and C among patients looking for hospital Care; five years\u2019 study in Mashhad, Iran. Acta Med Iran. 2016;54(1):54\u20137.","journal-title":"Acta Med Iran"},{"issue":"2","key":"508_CR61","first-page":"134","volume":"64","author":"MJ Zahedi","year":"2014","unstructured":"Zahedi MJ, Moghaddam SD, Abasi MH, Parnian M, Shokoohi M, Hepatitis B. C virus co-infection and behavioral risks in HIV-positive patients in Southern Iran. J Pak Med Assoc. 2014;64(2):134\u20137.","journal-title":"J Pak Med Assoc"},{"key":"508_CR62","doi-asserted-by":"crossref","unstructured":"Ziaee M, Azarkar G. Prevalence of hepatitis D virus infection among patients with chronic hepatitis B attending Birjand hepatitis clinic (East of Iran) in 2012. Hepat Mon. 2013;13(8).","DOI":"10.5812\/hepatmon.11168"},{"issue":"3","key":"508_CR63","first-page":"188","volume":"10","author":"B Ataei","year":"2010","unstructured":"Ataei B, Tayeri K, Kassaian N, Farajzadegan Z, Babak A. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, iran: Seroprevalence and associated factors. Hepat Mon. 2010;10(3):188\u201392.","journal-title":"Hepat Mon"},{"issue":"6","key":"508_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1684-1182(10)60080-1","volume":"43","author":"AHM Alizadeh","year":"2010","unstructured":"Alizadeh AHM, Ranjbar M, Tehrani ASS, Keramat F, Mamani M, Rezazadeh M, et al. Seroprevalence of hepatitis D virus and its risk factors in the West of Iran. J Microbiol Immunol Infect. 2010;43(6):519\u201323.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"508_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18502\/rmm.v5i4.3066","volume":"5","author":"M Bakhti","year":"2017","unstructured":"Bakhti M, Haghshenas M, Valadan R, Rudsari MR. Prevalence of HBV\/HCV infections in HIV-positive patients in Northern Iran. RMM. 2017;5(4):61\u20138.","journal-title":"RMM"},{"key":"508_CR66","doi-asserted-by":"crossref","unstructured":"Naderi M, Hosseini SM, Behnampour N, Shahramian I, Moradi A. Determining the prevalence of hepatitis delta virus, hepatitis C virus, and HIV among mothers and infants with hepatitis B virus chronic infection. Jundishapur J Microbiol. 2022;15(7).","DOI":"10.5812\/jjm-127879"},{"issue":"5","key":"508_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5812\/hepatmon.5969","volume":"12","author":"MJ Zahedi","year":"2012","unstructured":"Zahedi MJ, Moghaddam SD, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV infection among Hemodialysis patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12(5):339\u201343.","journal-title":"Hepat Mon"},{"issue":"4","key":"508_CR68","first-page":"252","volume":"8","author":"S Vaziri","year":"2008","unstructured":"Vaziri S, Mansouri F, Sayad B, Afsharian M, Janbakhsh A, Karami M. Hepatitis D virus infection among HIV-HBV Co-Infected patients in Kermanshah, West of Iran. Hepat Mon. 2008;8(4):252\u20137.","journal-title":"Hepat Mon"},{"issue":"12","key":"508_CR69","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5812\/kowsar.1735143X.4148","volume":"11","author":"SME Tahaei","year":"2011","unstructured":"Tahaei SME, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, et al. Frequency of HIV and HCV Co-Infections in chronic HBV patients referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011;11(12):993\u20136.","journal-title":"Hepat Mon"},{"issue":"4","key":"508_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/ADM.0b013e3182659928","volume":"6","author":"M Sofian","year":"2012","unstructured":"Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, et al. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med. 2012;6(4):292\u20136.","journal-title":"J Addict Med"},{"issue":"77","key":"508_CR71","first-page":"29","volume":"22","author":"M Sofian","year":"2017","unstructured":"Sofian M, Ramezani A, Tavana M, Ghaznavi-Rad E, Sharif MR, Banifazl M, et al. Frequency of hepatitis D virus infection in chronic hepatitis B patients in Arak. Iran J Infect Dis Trop Med. 2017;22(77):29\u201331.","journal-title":"Iran J Infect Dis Trop Med"},{"issue":"13","key":"508_CR72","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3923\/pjbs.2006.2538.2540","volume":"9","author":"S Semnani","year":"2006","unstructured":"Semnani S, Roshandel G, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, et al. HBV\/HCV co-infection in iran: A seroepidemiological based study. Pak J Biol Sci. 2006;9(13):2538\u201340.","journal-title":"Pak J Biol Sci"},{"issue":"9","key":"508_CR73","first-page":"1122","volume":"26","author":"A Ramezani","year":"2014","unstructured":"Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, et al. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. Asp AIDS\/HIV. 2014;26(9):1122\u20136.","journal-title":"Asp AIDS\/HIV"},{"issue":"1","key":"508_CR74","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1016\/j.ijid.2009.03.002","volume":"14","author":"A Rahimi-Movaghar","year":"2010","unstructured":"Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010;14(1):E28\u201333.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"508_CR75","first-page":"14","volume":"19","author":"A Mokhtarifar","year":"2014","unstructured":"Mokhtarifar A, Rezvani HR, Esmaielzadeh A, Ghaffarzadegan K, Goshayeshi L. The prevalence of HIV and transmission risk factors among hepatitis B and C patients referred to Emam Reza hospital, Mashhad, Iran from 2005\u20132008. Govaresh. 2014;19(1):14\u20139.","journal-title":"Govaresh"},{"issue":"3","key":"508_CR76","first-page":"623","volume":"79","author":"H Mokhayeri","year":"2024","unstructured":"Mokhayeri H, Hasanvand B, Birjandi M, Mirzaei H, Sasaei P, Zamani S, et al. Prevalence of HIV, HBV, and HCV infections and high-risk behaviors among women referred to drop-in centers in Lorestan Province, Western Iran. Arch Razi Inst. 2024;79(3):623\u20138.","journal-title":"Arch Razi Inst"},{"issue":"12","key":"508_CR77","first-page":"3267","volume":"18","author":"M Mohsenizadeh","year":"2017","unstructured":"Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological study of hepatitis B, C and HIV among blood donors in Kerman. APJCP. 2017;18(12):3267\u201372.","journal-title":"APJCP"},{"key":"508_CR78","doi-asserted-by":"crossref","unstructured":"Khajedaluee M, Babaei A, Vakili R, Valizade N, Shandiz FH, Alavian SM et al. Sero-Prevalence of bloodborne tumor viruses (HCV, HBV, HTLV-I and KSHV Infections) and related risk factors among prisoners in Razavi Khorasan Province, Iran, in 2008. Hepat Mon. 2016;16(12).","DOI":"10.5812\/hepatmon.31541"},{"key":"508_CR79","first-page":"S17","volume":"19","author":"A Javadi","year":"2014","unstructured":"Javadi A, Ataei B, Kassaian N, Nokhodian Z, Yaran M. Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop-in centers. J Res Med Sci. 2014;19:S17\u201321.","journal-title":"J Res Med Sci"},{"issue":"4","key":"508_CR80","first-page":"285","volume":"40","author":"A Karimi","year":"2008","unstructured":"Karimi A, Hoseini SM. Seroprevalence of hepatitis B and C virus and HIV markers among blood donors from Shahre-Kord, Iran (2004\u20132006). Kuwait Med J. 2008;40(4):285\u20137.","journal-title":"Kuwait Med J"},{"issue":"1","key":"508_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/hepatmon.101630","volume":"21","author":"M Hajiabdolbaghi","year":"2021","unstructured":"Hajiabdolbaghi M, Abdiliae Z, Bayani J, Qaempanah M, Ghiasvand F. Characteristics of hepatitis b and d co-infection: A descriptive study. Hepat Mon. 2021;21(1):1\u20134.","journal-title":"Hepat Mon"},{"key":"508_CR82","unstructured":"Cohan N, Zandieh T, Samiei S, Ataie Z, Kavari M. The prevalence and clinical significance of hepatitis B and C Coinfection. IJMS. 2006. 31(3)."},{"issue":"3","key":"508_CR83","first-page":"53","volume":"1","author":"Z Aminzadehv","year":"2007","unstructured":"Aminzadehv Z, Aghazadeh Sarhangi K. Seroepidemiology of HIV, syphilis, hepatitis B and C in intravenous drug users at Loghman Hakim hospital. Iran J Med Microbiol. 2007;1(3):53\u20136.","journal-title":"Iran J Med Microbiol"},{"issue":"2","key":"508_CR84","first-page":"45","volume":"6","author":"SM Alavian","year":"2003","unstructured":"Alavian SM, Ardeshiri A, Hajarizadeh B, Prevalence Of HCV. HBV, and HIV infections among hemophiliacs. Hakim Res J. 2003;6(2):45\u201351.","journal-title":"Hakim Res J"},{"issue":"4","key":"508_CR85","first-page":"7","volume":"9","author":"S Amini Kafiabad","year":"2007","unstructured":"Amini Kafiabad S, Taghi Nia A, Khan Baba F, Talebian A. Prevalence of delta agent Super-Infection and Co-Infection among Hbsag-Positive patients referring to reference Ibto lab. Hakim J. 2007;9(4):7\u201311.","journal-title":"Hakim J"},{"issue":"1","key":"508_CR86","first-page":"33","volume":"32","author":"S Jedari Seyfi","year":"2010","unstructured":"Jedari Seyfi S, Ghoutaslou R, Torabi SE. Seroepidemiology of hepatitis delta virus (Hdv), in A group of hepatitis B surface antigen positive in Tabriz. Med J Tabriz Univ Med Sci. 2010;32(1):33\u20138.","journal-title":"Med J Tabriz Univ Med Sci."},{"key":"508_CR87","unstructured":"Salman Roughani H. Prevalence of hepatitis B cab with or without anti HBsAb in HBsAg seronegative blood donors. JSSU. 2005; 12(4):10."},{"issue":"1","key":"508_CR88","first-page":"83","volume":"24","author":"MJ Barkhordari Kh, Zahedi","year":"2016","unstructured":"Barkhordari Kh, Zahedi MJ, Pouyandeh Ravan AR, Molaie H, Arab-Zadeh SAM. Prevalence, and genotyping of hepatitis d virus among HBs ag positive patients referred to besat clinic, Kerman during 2012\u20132013. J Shahid Sadoughi Univ Med Sci. 2016;24(1):83\u201392.","journal-title":"J Shahid Sadoughi Univ Med Sci"},{"issue":"2","key":"508_CR89","first-page":"69","volume":"53","author":"SM Hosseini","year":"2010","unstructured":"Hosseini SM, Esmaeilzadeh A, Mokhtarifar A, Sima HR, Vosughi H, Saadatnia H, Ahmad K. Seroepidemiology and Co- infections of hepatitis D virus infection in the North- East of Iran. Med J Mashhad Univ Med Sci. 2010;53(2):69\u201372.","journal-title":"Med J Mashhad Univ Med Sci"},{"key":"508_CR90","unstructured":"Azarkar Z, Gh S, Miraki MA. HBV, HCV, and HIV prevalence among - south Khorasan prisoners. Birjand Univ Med Sci. 2007; 14(2)."},{"issue":"5","key":"508_CR91","first-page":"41","volume":"1","author":"A Ebrahimzadeh","year":"2023","unstructured":"Ebrahimzadeh A, Alemzadeh E, Mohammadifard M, Askari P. Comparison of serologic and sonographic findings in patients with HBV\/HDV and HBV\/HCV infections. J Title. 2023;1(5):41\u20136.","journal-title":"J Title"},{"issue":"1","key":"508_CR92","first-page":"47","volume":"7","author":"Z Honarkar","year":"2004","unstructured":"Honarkar Z, Alaviyan M, Samiei S, Saeedfar K, Baladast M, Aghazadeh R, et al. Serological and molecular evidence of hepatitis B in patients with chronic hepatitis C. J Arak Uni Med Sci. 2004;7(1):47\u201353.","journal-title":"J Arak Uni Med Sci"},{"issue":"4","key":"508_CR93","first-page":"295","volume":"8","author":"M Kazemi Arababadi","year":"2009","unstructured":"Kazemi Arababadi M, Hassanshahi M, Rezaeian M, Rezazadeh Zarandi E, Vazirinejad R. Evaluation of occult hepatitis B virus infection in thalassemic patients infected by HCV in Kerman Province of Iran. J Rafsanjan Univ Med Sci. 2009;8(4):295\u2013302.","journal-title":"J Rafsanjan Univ Med Sci"},{"issue":"1","key":"508_CR94","first-page":"25","volume":"29","author":"E Hasanpour","year":"2003","unstructured":"Hasanpour E, Arasteh E, Mahdvi S, Prevalence of Hepatitis B. Hepatitis C and HIV infection in 15 year and older patients admitted in hand surgery emergency. Sci J Kurdistan Univ Med Sci. 2003;29(1):25\u201331.","journal-title":"Sci J Kurdistan Univ Med Sci"},{"key":"508_CR95","first-page":"42","volume":"11","author":"H Kazerani","year":"2007","unstructured":"Kazerani H. Epidemiological study of positive samples in HCV, HBV and, HIV in heart disease and surgical diseases in Imam Ali hospital in Kermanshah. SJKUMS. 2007;11:42\u20137.","journal-title":"SJKUMS"},{"key":"508_CR96","unstructured":"Torabi SE, Ebrahimpoor S, Maljaie SH, Naghili B. Seroepidemiological studies of hepatitis delta (HDV) in HbsAg positive individuals in Tabriz. UMJ. 2003; 13(4)."},{"issue":"4","key":"508_CR97","first-page":"301","volume":"15","author":"F Taheri","year":"2019","unstructured":"Taheri F, Tajbakhsh E, Heidari Soureshjani E. Molecular detection of HCV, and HBV in HIV positive patients in Chaharmahal and Bakhtiari Province. Sci J Iran Blood Transfus Organ. 2019;15(4):301\u20139.","journal-title":"Sci J Iran Blood Transfus Organ"},{"key":"508_CR98","doi-asserted-by":"crossref","unstructured":"Saleh F, Azizi H, Kheirandish F, Rashnou F, Mousavi Nasab SD, Movahedi F, Azizi M. Frequency of HCV and HBV Co-infections in HIV positive patients in the City of iran: a cross-sectional study. Int J Trop Dis Health. 2015; 6(1): 14\u20139.","DOI":"10.9734\/IJTDH\/2015\/13282"},{"issue":"3","key":"508_CR99","first-page":"174","volume":"4","author":"L Shahinsaz","year":"2006","unstructured":"Shahinsaz L, Sabahi F, Karimi M, Behzadian F, Alavian SM, Zand V. Detection and genotyping of hepatitis D virus from HBsAg positive patients in Iran using RT-PCR. Iran J Biotechnol. 2006;4(3):174\u20139.","journal-title":"Iran J Biotechnol"},{"issue":"1","key":"508_CR100","first-page":"53","volume":"27","author":"M Hosseini Rad","year":"2017","unstructured":"Hosseini Rad M, Jamshidi Makiani M, Kalantari S, Sohrabi S, Ahmadniya H, Zanganeh M. The study of Seroprevalence of hepatitis B and hepatitis C and behavioral factors in HIV patients referred to the consultation clinics of Tehran behavioral diseases health center. Med Sci. 2017;27(1):53\u201361.","journal-title":"Med Sci"},{"issue":"4","key":"508_CR101","first-page":"181","volume":"2","author":"M Nassiri Toosi","year":"2007","unstructured":"Nassiri Toosi M, Larti F, Rasteh M, Foroutan H, Salarieh N, Lessan-Pezeshki M, Abdollahi A, Seifi S, Razeghi E, Rahbar M. Risk factors and Seroprevalence of hepatitis B and C infections among Hemodialysis patients in Tehran. Iran J Pathol. 2007;2(4):181\u20136.","journal-title":"Iran J Pathol"},{"issue":"5","key":"508_CR102","first-page":"448","volume":"40","author":"M Motamedifar","year":"2015","unstructured":"Motamedifar M, Taheri M, Lankarani KB, Gholami M, Lari MA, Faramarzi H, Sarvari J. The prevalence and risk factors of hepatitis delta virus in HIV\/HBV Co-Infected patients in Shiraz, Iran, 2012. Iran J Med Sci. 2015;40(5):448\u201353.","journal-title":"Iran J Med Sci"},{"issue":"2","key":"508_CR103","first-page":"93","volume":"22","author":"H Foroutan","year":"2008","unstructured":"Foroutan H, Nemati A, Nasiri-Tosi M, Ghofrani H, Keivani H. Prevalence of hepatitis delta virus infection in various groups with HBV infection in Tehran, Imam Khomeini hospital (2005\u20132006). MJIRI. 2008;22(2):93\u20137.","journal-title":"MJIRI"},{"issue":"4","key":"508_CR104","first-page":"230","volume":"20","author":"T Khazaee","year":"2015","unstructured":"Khazaee T, Ebrahimzadeh A, Moghaddam E, Ghafori M. Assessment of prevalence and determine infections of hepatitis C and hepatitis D in patients with chronic hepatitis B. Govaresh. 2015;20(4):230\u20136.","journal-title":"Govaresh"},{"issue":"1","key":"508_CR105","first-page":"21","volume":"10","author":"SM Alavian","year":"2005","unstructured":"Alavian SM, Assari Sh, Manzoori-Joybari H, Moghani Lankarani M, Doroudi T, Haji-Beigi B, Hajarizade B. Frequency and risk factors of hepatitis D virus in hepatitis B patients. Govaresh. 2005;10(1):21\u20136.","journal-title":"Govaresh"},{"issue":"1","key":"508_CR106","first-page":"1","volume":"6","author":"M Khani","year":"2003","unstructured":"Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infection in drug addicts among Zanjan prisoners. Arch Iran Med. 2003;6(1):1\u20134.","journal-title":"Arch Iran Med"},{"issue":"139","key":"508_CR107","first-page":"46","volume":"22","author":"S Daryazadeh","year":"2016","unstructured":"Daryazadeh S, Kuhpayehzadeh J. Prevalence of simultaneous infections and causes of death of positive-HIV patients in incubation and AIDS phases. Razi J Med Sci. 2016;22(139):46\u201354.","journal-title":"Razi J Med Sci"},{"issue":"1","key":"508_CR108","first-page":"e84112","volume":"6","author":"F Bineshian","year":"2019","unstructured":"Bineshian F, Sharifi Z. The prevalence of hepatitis delta virus in patients with chronic hepatitis B and its association with risk factors. Middle East J Rehabil Health Stud. 2019;6(1):e84112.","journal-title":"Middle East J Rehabil Health Stud"},{"issue":"4","key":"508_CR109","first-page":"159","volume":"17","author":"SH Seyed Hoseinian","year":"2020","unstructured":"Seyed Hoseinian SH, Bagheri F, Birjandi Nejad A, Peivandi MT, Ebrahimzadeh MH. Prevalence of hepatitis B, hepatitis C and human immunodeficiency virus among trauma patients: A study on 27000 trauma patients. IJOS. 2020;17(4):159\u201362.","journal-title":"IJOS"},{"issue":"4","key":"508_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21859\/isv.6.4.1","volume":"6","author":"S Rostami","year":"2012","unstructured":"Rostami S, Shakeri M, Ghayour-Mobarhan M, Nomani H, Sepahi S, Gerayli S, et al. The absence of hepatitis C virus infection among patients with hepatitis B virus in Mashhad, Iran. Iran J Virol. 2012;6(4):1\u20136.","journal-title":"Iran J Virol"},{"key":"508_CR111","doi-asserted-by":"crossref","unstructured":"Jonaidi-Jafari N, Rezaee-Zavareh MS, Tavallaei-Nosratabadi J, Ajudani R, Ramezani-Binabaj M, Karimi-Sari H et al. Occult hepatitis B infection in hepatitis C patients with hematological disorders. JJM. 2017; 10(2).","DOI":"10.5812\/jjm.40816"},{"key":"508_CR112","doi-asserted-by":"crossref","unstructured":"Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E et al. Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in Tehran-Iran. Hepat Mon. 2013;13(5).","DOI":"10.5812\/hepatmon.10134"},{"issue":"7","key":"508_CR113","doi-asserted-by":"publisher","first-page":"803","DOI":"10.26719\/emhj.19.077","volume":"26","author":"MH Somi","year":"2020","unstructured":"Somi MH, Khayatzadeh S, Nalbandy M, Naghashi S, Nikniaz Z. Estimating the incidence rate of hepatitis B and C in East Azerbaijan, Islamic of Iran. East Mediterr Health J. 2020;26(7):803\u20139.","journal-title":"East Mediterr Health J"},{"issue":"2","key":"508_CR114","first-page":"147","volume":"19","author":"T Zandieh","year":"2005","unstructured":"Zandieh T, Cohan N, Samiei S, Amini S, Ataei Z, Kavari M. Characteristics, and prevalence of occult hepatitis B virus infection in patients with hepatitis C in Iran. Med J Islam Repub Iran. 2005;19(2):147\u201351.","journal-title":"Med J Islam Repub Iran"},{"issue":"17","key":"508_CR115","doi-asserted-by":"publisher","first-page":"e37097","DOI":"10.1016\/j.heliyon.2024.e37097","volume":"10","author":"S Delghandi","year":"2024","unstructured":"Delghandi S, Raoufinia R, Shahtahmasbi S, Meshkat Z, Gouklani H, Gholoobi A. An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination. Heliyon. 2024;10(17):e37097.","journal-title":"Heliyon"},{"key":"508_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7150\/ijms.2.50","volume":"2","author":"J Hou","year":"2005","unstructured":"Hou J, Liu Z, Gu F. Epidemiology, and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50.","journal-title":"Int J Med Sci"},{"key":"508_CR117","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11904-014-0206-z","volume":"11","author":"S Ye","year":"2014","unstructured":"Ye S, Pang L, Wang X, Liu Z. Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia. Curr HIV\/AIDS Rep. 2014;11:128\u201333.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9","key":"508_CR118","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00705-020-04716-1","volume":"165","author":"R Rashti","year":"2020","unstructured":"Rashti R, Alavian SM, Moradi Y, Sharafi H, Mohamadi Bolbanabad A, Roshani D, Moradi G. Global prevalence of HCV and\/or HBV coinfections among people who inject drugs and female sex workers who live with HIV\/AIDS: a systematic review and meta-analysis. Arch Virol. 2020;165(9):1947\u201358.","journal-title":"Arch Virol"},{"key":"508_CR119","doi-asserted-by":"crossref","unstructured":"Anvari HZ, Binabaj MM, Asadi A, Abdi M, Shakiba A, Heidary M, Sholeh M. Epidemiology of HBV-HCV coinfection among Iranian patients: a systematic review and meta-analysis. Clin Lab. 2023; 69(11).","DOI":"10.7754\/Clin.Lab.2023.230503"},{"key":"508_CR120","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/pathogens9060432","volume":"9","author":"R Rashti","year":"2020","unstructured":"Rashti R, Sharafi H, Alavian SM, Moradi Y, Mohamadi Bolbanabad A, Moradi G. Systematic review and Meta-Analysis of global prevalence of HBsAg and HIV and HCV antibodies among people who inject drugs and female sex workers. Pathogens. 2020;9:432.","journal-title":"Pathogens"},{"issue":"1","key":"508_CR121","first-page":"57","volume":"22","author":"A Esmaeilzadeh","year":"2017","unstructured":"Esmaeilzadeh A, Goshayeshi L, Bahari A, Ganji A, Mosannen Mozaffari H. Regional distribution of hepatitis delta virus in iran: A systematic literature review. Govaresh. 2017;22(1):57\u201363.","journal-title":"Govaresh"},{"issue":"4","key":"508_CR122","doi-asserted-by":"publisher","first-page":"e35577","DOI":"10.5812\/hepatmon.35577","volume":"16","author":"M Salehi-Vaziri","year":"2016","unstructured":"Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B virus infection in the general population of iran: an updated systematic review and Meta-Analysis. Hepat Mon. 2016;16(4):e35577.","journal-title":"Hepat Mon"},{"key":"508_CR123","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41598-017-18296-9","volume":"8","author":"S Mahmud","year":"2018","unstructured":"Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in iran: systematic review and meta-analyses. Sci Rep. 2018;8:150.","journal-title":"Sci Rep"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-025-00508-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:04:28Z","timestamp":1767801868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-025-00508-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s44197-025-00508-5","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in full compliance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval for the protocol was obtained from the Ethics Committee of Golestan University of Medical Sciences (approval code: IR.GOUMS.REC.1404.107). Not applicable for consenting to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable\u201d in the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"2"}}